We estimate that the CEO of Tyra Biosciences, Inc. ($TYRA), Todd Harris, Ph.D., received a compensation of $5,566,997 in 2025. This is a decrease of -35.98% from an estimated $7,570,066 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 17, 2026. Note that parsing errors may occur.
You can track $TYRA on Quiver Quantitative's $TYRA stock dashboard.
$TYRA Stock Insider Trading Activity
$TYRA Stock insiders have traded $TYRA stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $TYRA stock by insiders over the last 6 months:
- ROBERT J MORE has made 0 purchases and 2 sales selling 256,871 shares for an estimated $5,250,026.
- DANIEL BENSEN (Chief Discovery Officer) has made 0 purchases and 9 sales selling 273,000 shares for an estimated $4,548,335.
- GILLA KAPLAN sold 14,295 shares for an estimated $528,506
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TYRA Stock Hedge Fund Activity
We have seen 66 institutional investors add shares of $TYRA Stock stock to their portfolio, and 48 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BVF INC/IL removed 1,522,129 shares (-41.7%) from their portfolio in Q4 2025, for an estimated $40,016,771
- FARALLON CAPITAL MANAGEMENT LLC added 923,000 shares (+80.7%) to their portfolio in Q4 2025, for an estimated $24,265,670
- KYNAM CAPITAL MANAGEMENT, LP removed 765,506 shares (-32.9%) from their portfolio in Q4 2025, for an estimated $20,125,152
- POINT72 ASSET MANAGEMENT, L.P. added 592,160 shares (+210.0%) to their portfolio in Q4 2025, for an estimated $15,567,886
- BOONE CAPITAL MANAGEMENT LLC added 398,482 shares (+inf%) to their portfolio in Q4 2025, for an estimated $10,476,091
- STATE STREET CORP added 320,991 shares (+74.9%) to their portfolio in Q4 2025, for an estimated $8,438,853
- WALLEYE CAPITAL LLC removed 297,808 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $7,829,372
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$TYRA Stock Analyst Ratings
Wall Street analysts have issued reports on $TYRA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 02/24/2026
To track analyst ratings and price targets for $TYRA Stock, check out Quiver Quantitative's $TYRA forecast page.
$TYRA Stock Price Targets
Multiple analysts have issued price targets for $TYRA recently. We have seen 8 analysts offer price targets for $TYRA in the last 6 months, with a median target of $51.5.
Here are some recent targets:
- Brad Canino from Guggenheim set a target price of $54.0 on 04/15/2026
- John Newman from Canaccord Genuity set a target price of $50.0 on 04/06/2026
- Allison Bratzel from Piper Sandler set a target price of $56.0 on 03/20/2026
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $45.0 on 02/17/2026
- Robert Driscoll from Wedbush set a target price of $53.0 on 02/13/2026
- Maury Raycroft from Jefferies set a target price of $43.0 on 02/03/2026
- Matthew Biegler from Oppenheimer set a target price of $50.0 on 02/03/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
